Levetiracetam Tablet, Film Coated
Product Images NDC 70518-1796

12 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-1796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetamtabletsstructure (Levetiracetamtabletsstructure)

Levetiracetamtabletsstructure (Levetiracetamtabletsstructure)
Chemical structure of levetiracetam showing its molecular framework with a pyrrolidone ring, ethyl group, methyl group, and amide side chain.*
FDA Label Image

Levetiracetamtabletsfigure1 (Levetiracetamtabletsfigure1)

Levetiracetamtabletsfigure1 (Levetiracetamtabletsfigure1)
Bar chart showing the percentage of patients in three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The y-axis represents the percentage of patients, and the x-axis shows the treatment groups with the number of patients in each group.*
FDA Label Image

Levetiracetamtabletsfigure2 (Levetiracetamtabletsfigure2)

Levetiracetamtabletsfigure2 (Levetiracetamtabletsfigure2)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis represents the percentage of patients, ranging from 0% to 45%. The chart shows values of 6.3% for the placebo group, 20.8% for the 1000 mg/day group, and 35.2% for the 2000 mg/day group. Sample sizes (N) are indicated below each group label.*
FDA Label Image

Levetiracetamtabletsfigure3 (Levetiracetamtabletsfigure3)

Levetiracetamtabletsfigure3 (Levetiracetamtabletsfigure3)
A bar chart comparing the percentage of patients between a placebo group (N=104) and a Levetiracetam 3000 mg/day group (N=180). The chart shows 14.4% of patients in the placebo group and 39.4% of patients in the Levetiracetam group, with the Levetiracetam bar marked by an asterisk.*
FDA Label Image

Levetiracetamtabletsfigure4 (Levetiracetamtabletsfigure4)

Levetiracetamtabletsfigure4 (Levetiracetamtabletsfigure4)
Bar chart comparing the percentage of patients between a placebo group (N=97) and a Levetiracetam group (N=101). The placebo group shows 19.6% of patients, while the Levetiracetam group shows 44.6%. The y-axis ranges from 0% to 45% of patients.*
FDA Label Image

Levetiracetamtabletsfigure5 (Levetiracetamtabletsfigure5)

Levetiracetamtabletsfigure5 (Levetiracetamtabletsfigure5)
A bar chart comparing the percentage of patients between placebo and levetiracetam groups. The x-axis shows 'Placebo (N=51)' and 'Levetiracetam (N=58)', and the y-axis represents the percentage of patients from 0% to 45%. The placebo group has about 19.6% of patients, while the levetiracetam group has about 43.1%, marked with an asterisk above the bar.*
FDA Label Image

Levetiracetamtabletsfigure6 (Levetiracetamtabletsfigure6)

Levetiracetamtabletsfigure6 (Levetiracetamtabletsfigure6)
A bar chart comparing the percentage of patients in two groups: Placebo and Levetiracetam. The y-axis represents the percentage of patients from 0% to 100%. The Placebo group (N=84) shows 45.2%, while the Levetiracetam group (N=79) shows 72.2%, with an asterisk marking the latter value.*
FDA Label Image

Mm1 (Levetiracetam 500mg 70518 1796 00)

Mm1 (Levetiracetam 500mg 70518 1796 00)
Levetiracetam 500 mg film-coated tablets, quantity 30, labeled by RemedyRepack Inc. The label includes the NDC number 70518-1796-00, repackaging information, storage directions, and a QR code. Manufacturer is Camber Pharma, Inc., Piscataway, NJ.*
FDA Label Image

Mm2 (Levetiracetam 500mg 70518 1796 01)

Mm2 (Levetiracetam 500mg 70518 1796 01)
Levetiracetam 500 mg film-coated tablet label showing quantity of 60 tablets. The label features the brand RemedyRepack with a purple and black design. It includes NDC number 70518-1796-01, manufacturer information for Camber Pharma Inc., and storage instructions. Directions for use refer to the package insert.*
FDA Label Image

Mm3 (Levetiracetam 500mg 70518 1796 02)

Mm3 (Levetiracetam 500mg 70518 1796 02)
Levetiracetam 500 mg film-coated tablet label shows a quantity of 60 tablets. The label includes the NDC 70518-1796-02 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufacturer is Camber Pharma, Inc., Piscataway, NJ. Storage instructions specify 20-25°C with permitted excursions.*
FDA Label Image

Mm4 (Levetiracetam 500mg 70518 1796 03)

Mm4 (Levetiracetam 500mg 70518 1796 03)
Levetiracetam 500 mg film-coated tablets packaging label with a quantity of 60 tablets. The label includes the NDC number 70518-1796-03 and states the product is repackaged by RemedyRepack Inc., Indiana, PA. It also provides storage instructions, manufacturer details (Camber Pharma, Inc., Piscataway, NJ), and a QR code.*
FDA Label Image

Mm5 (Levetiracetam 500mg 70518 1796 04)

Mm5 (Levetiracetam 500mg 70518 1796 04)
Levetiracetam 500 mg film-coated tablet label showing a quantity of 30 tablets per package. The label includes the NDC number 70518-1796-04 and specifies repackaging by RemedyRepack Inc., located in Indiana, PA. Storage instructions, dosage reference, and manufacturer information for Camber Pharma, Inc. are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.